HIGHLIGHTS
- who: L.H.J. Holtkamp from the (UNIVERSITY) have published the research: Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma, in the Journal: (JOURNAL)
- what: The aim of this study was to compare the oncological outcomes of hypofractionated and conventionally fractionated adjuvant radiotherapy following regional lymph node dissection for high-risk melanoma metastases in patients treated in an era before effective systemic therapy.
- future: Future studies should investigate the benefit of radiotherapy in patients with high-risk nodal disease receiving contemporary adjuvant systemic therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.